NCT05611294 is a NA clinical trial of Topography Guided LASIK Surgery in Myopia, sponsored by Hoopes Vision.

Who is sponsoring NCT05611294?

NCT05611294 is sponsored by Hoopes Vision.

What drugs are being tested in NCT05611294?

Interventions in NCT05611294: Topography Guided LASIK Surgery, Small Incision Lenticule Extraction Surgery.

What condition does NCT05611294 study?

NCT05611294 studies Myopia, Astigmatism.

Is NCT05611294 still recruiting?

NCT05611294 is currently active, enrolled. Last updated 1 August 2024.

Last reviewed 2024-08-01 · How we verify

NCT05611294

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

Active, enrolled NA Last updated 1 August 2024

What this trial tests

NA trial testing Topography Guided LASIK Surgery in Myopia in 42 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

27 September 2022

Primary endpoint
1 May 2025

1 June 2025

Quick facts

Lead sponsor	Hoopes Vision
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	42
Start date	27 September 2022
Primary completion	1 May 2025
Estimated completion	1 June 2025
Sites	1 location across United States

Drugs / interventions tested

Topography Guided LASIK Surgery
Small Incision Lenticule Extraction Surgery

Conditions studied

Myopia — all drugs for Myopia →
Astigmatism — all drugs for Astigmatism →

Sponsor

Hoopes Vision

Who can join

Adults 22 to 50, any sex, with Myopia or Astigmatism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates differences in postoperative visual outcomes between patients receiving Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Three-Month Comprehensive Outcomes of Topography-Guided LASIK Versus Keratorefractive Lenticule Extraction (KLEx): A Prospective Contralateral Study.
Moin KA, Manion GN, Pandiri S, Hoopes PC, et al · · 2024 · cited 4× · PMID 38951314 · DOI 10.1007/s40123-024-00987-y

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05611294 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hoopes Vision
Last refreshed: 1 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05611294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing